The NEXT Lab at Hanyang University develops nanoparticle platforms to advance immune-based therapeutics.
Our research focuses on APC-targeted delivery systems for next-generation vaccines and on nanomedicine for treating cancer and inflammatory diseases.
We aim to translate engineered biomaterials into practical therapies by bridging nanoscience and immunology.